Turbare Avastin 1.25 mg Syringe Recall: Lack of Sterility Risk
Turbare recalls Avastin 1.25 mg/0.05 mL syringes due to lack of sterility assurance. Affected lots have specific batch numbers and expiration dates. Stop using immediately to avoid infection risks.
Stop using this now
Lack of Assurance of Sterility: due to a quality control process deviation
Contact the company
What happened, in plain English
Turbare is recalling Avastin 1.25 mg syringes because a quality control issue may have caused them to lack sterility. This could lead to infections if used for eye injections. Affected products have specific batch numbers and expiration dates. Read more at govinfonow.com/recall/32271-turbare-avastin-1-25-mg-syringe-recall-lack-of-sterility.
Source Summary by GovInfoNow · govinfonow.com/recall/32271-turbare-avastin-1-25-mg-syringe-recall-lack-of-sterility · Updated August 17, 2026 · FDA enforcement record: FDA #D-0248-2025
Cite this page
“Turbare Avastin 1.25 mg Syringe Recall: Lack of Sterility Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32271-turbare-avastin-1-25-mg-syringe-recall-lack-of-sterility. Based on FDA recall #D-0248-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0248-2025%22&limit=1).
Why it’s dangerous
The quality control process deviation means the syringes might not be sterile. If used for eye injections, this could cause serious infections or other complications.
Who’s affected
Patients receiving intravitreal eye injections from healthcare providers using the recalled syringes. Those with the specific batch numbers and expiration dates are most at risk.
How to tell if you have this one
Check for batch numbers 12122024@2 (expires 3/12/2025) or 12192024@2 (expires 4/18/2025) on the syringe label. The product is for office use only and not for resale.
- Brand
Turbare- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the syringe if you have the recalled batch numbers.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0248-2025 (February 18, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0248-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.